CRISPR Therapeutics AG (CRSP) |
|
38.83 -0.61 (-1.55%)
|
05-17 16:00 |
|
Open: |
38.95 |
Pre. Close: |
39.44 |
|
High:
|
39.36 |
Low:
|
38.2475 |
|
Volume:
|
296,821 |
Market Cap:
|
2053M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
39.402 - 39.628 |
39.628 - 39.832 |
|
Low:
|
37.735 - 37.979 |
37.979 - 38.199 |
|
Close:
|
38.475 - 38.871 |
38.871 - 39.227 |
|
|
|
Technical analysis |
as of: 2019-05-17 4:27:37 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 46.72 One year: 50.22 |
| Support: |
Support1: 35.15 Support2: 29.24 |
| Resistance: |
Resistance1: 40.00 Resistance2: 43.00 |
| Pivot: |
39.61 |
| Moving Average: |
MA(5): 38.46 MA(20): 39.46 
MA(100): 35.58 MA(250): 43.13 |
| MACD: |
MACD(12,26): 0.26 Signal(9): 0.49 |
| Stochastic oscillator: |
%K(14,3): 31.63 %D(3): 24.15 |
| RSI: |
RSI(14): 49.87 |
| 52-week: |
High: 73.90 Low: 22.22 Change(%): -40.0 |
| Average Vol(K): |
3-Month: 70239 10-Days: 44353 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.CRSP has closed above bottom band by 32.8%. Bollinger Bands are 45.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to CRSP's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Mon, 13 May 2019 18:06:48 Z
5 Growthy Biotech Stocks to Buy Despite the Scrutiny
Wed, 08 May 2019 14:15:01 Z
Why CRISPR Therapeutics Gained 13.4% in April
Tue, 07 May 2019 22:08:29 Z
CRSP Crosses Below Key Moving Average Level
Thu, 02 May 2019 21:09:04 Z
Vertex Pharmaceuticals Looks to Jump From 18,000 Patients to 68,000
Wed, 01 May 2019 18:12:20 Z
Vertex (VRTX) Q1 Earnings and Revenues Surpass Estimates
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
52.91 |
| Shares Float (M) |
51.08 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
52.50 |
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-3.430 |
|
EPS Est. Current Year
|
-2.430 |
|
EPS Est. Next Year
|
-3.020 |
|
EPS Est. Next Quarter
|
-0.740 |
|
Forward EPS
|
-3.299 |
|
Book Value (p.s.)
|
5.570 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
-8613.61 |
|
Return on Assets (ttm)
|
-44.1 |
|
Return on Equity (ttm)
|
-57.5 |
|
Qtrly Rev. Growth
|
-75.8 |
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-117.29 |
|
Levered Free Cash Flow (M)
|
-66.90 |
Stock Valuations |
|
P/E
|
-11.32 |
|
P/E Growth Ratio
|
-0.02 |
|
P/BV
|
6.97 |
|
P/S
|
51333263360.00 |
|
P/CF
|
-17.52 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
